Back to Feed
总结
多家媒体援引监管通报称，澳大利亚等地对疑似假冒的印度产狂犬病疫苗Abhayrab发出全球警示，引发对跨境药品供应链透明度与追溯能力的争论。涉事印度企业印度免疫制品有限公司表示产品“已无库存”并寻求复核，但印度药监机构CDSCO被指反应沉默。事件令接种安全、进口流通核验、召回与信息披露机制受到关注，可能促使各国强化药品溯源与监管协作。
正文
Global Alert on Counterfeit Rabies Vaccines Sparks Debate: Why Supply Chain Transparency is No Longer Optional openPR.com UPSC Mains Current Affairs for 30 December 2025 Vajiram & Ravi Counterfeit of anti-rabies vaccine no longer in stock: Indian Immunologicals Ltd The Hindu Abhayrab episode: Global regulators warn, CDSCO stays silent India Today Indian vaccine maker seeks review of Australian alert on counterfeit rabies shots Telegraph India
发布时间：